Evidence map›Paper›PMID 28432338›Full record

ArticleScientific reports2017

Crispr/Cas9 Mediated Inactivation of Argonaute 2 Reveals its Differential Involvement in Antiviral Responses.

Márta Ludman, József Burgyán, Károly Fátyol

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
12.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Plant-made pharmaceuticals.Plant biotechnology (Tokyo, Japan) · 2024
    Article
  5. Article
  6. Review
  7. Improving transient expression inFrontiers in plant science · 2024
    Article
  8. Article
  9. Article
  10. Green Biologics: Harnessing the Power of Plants to Produce Pharmaceuticals.International journal of molecular sciences · 2023
    Review
  11. Article
  12. Hsp70 and Hsp90 Elaborately Regulate RNAi Efficiency inInternational journal of molecular sciences · 2023
    Article
  13. Article
  14. Article
  15. Infection Defects of RNA and DNA Viruses Induced by Antiviral RNA Interference.Microbiology and molecular biology reviews : MMBR · 2023
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Márta LudmanAgricultural Biotechnology Institute, National Agricultural Research and Innovation Centre, Szent-Györgyi Albert u. 4, Gödöllő, 2100, Hungary.
József BurgyánAgricultural Biotechnology Institute, National Agricultural Research and Innovation Centre, Szent-Györgyi Albert u. 4, Gödöllő, 2100, Hungary. burgyan@abc.hu.
Károly FátyolAgricultural Biotechnology Institute, National Agricultural Research and Innovation Centre, Szent-Györgyi Albert u. 4, Gödöllő, 2100, Hungary. kfatyol@gmail.com.
Agricultural Biotechnology Institute · HUNational Agricultural Research and Innovation Centre · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA silencing constitutes an important antiviral mechanism in plants. Small RNA guided Argonaute proteins fulfill essential role in this process by acting as executors of viral restriction. Plants encode multiple Argonaute proteins of which several exhibit antiviral activities. A recent addition to this group is AGO2. Its involvement in antiviral responses is established predominantly by studies employing mutants of Arabidopsis thaliana. In the virological model plant, Nicotiana benthamiana, the contribution of AGO2 to antiviral immunity is much less certain due to the lack of appropriate genetic mutants. Previous studies employed various RNAi based tools to down-regulate AGO2 expression. However, these techniques have several disadvantages, especially in the context of antiviral RNA silencing. Here, we have utilized the CRISPR/Cas9 technology to inactivate the AGO2 gene of N. benthamiana. The ago2 plants exhibit differential sensitivities towards various viruses. AGO2 is a critical component of the plants' immune responses against PVX, TuMV and TCV. In contrast, AGO2 deficiency does not significantly influence the progression of tombusvirus and CMV infections. In summary, our work provides unequivocal proof for the virus-specific antiviral role of AGO2 in a plant species other than A. thaliana for the first time.

Indexed as

Argonaute ProteinsCRISPR-Cas SystemsNicotianaPlant DiseasesPlant ImmunityPlant ProteinsPlant VirusesTombusvirusArgonaute ProteinsPlant Proteins

Identifiers

PMID28432338
PMCPMC5430636
OpenAlexW2607146178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.